Promise and pitfalls of molecular markers of thyroid nodules
暂无分享,去创建一个
N. Shah | A. Lila | T. Bandgar | S. Jadhav
[1] E. Alexander,et al. Diagnostic use of molecular markers in the evaluation of thyroid nodules. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[2] Darya Chudova,et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.
[3] M. Zeiger,et al. The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology , 2012, Journal of surgical oncology.
[4] S. T. Dunn,et al. Cytologic and molecular diagnosis of thyroid cancers , 2012, Cancer cytopathology.
[5] R. Seethala,et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. , 2011, The Journal of clinical endocrinology and metabolism.
[6] R. Valcavi,et al. Is a five‐category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998–2007 , 2011, Cytopathology : official journal of the British Society for Clinical Cytology.
[7] R. Paschke,et al. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. , 2011, The Journal of clinical endocrinology and metabolism.
[8] M. Xing,et al. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. , 2010, Thyroid : official journal of the American Thyroid Association.
[9] H. Gharib,et al. AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES , 2010 .
[10] C. Croce,et al. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. , 2010, Endocrine-related cancer.
[11] F. Pacini,et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. , 2010, The Journal of clinical endocrinology and metabolism.
[12] Xuguang Zhu,et al. Lessons from mouse models of thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[13] Yuri E Nikiforov,et al. Molecular diagnostics and predictors in thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[14] M. Nikiforova,et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. , 2009, The Journal of clinical endocrinology and metabolism.
[15] G. Tseng,et al. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. , 2008, The Journal of clinical endocrinology and metabolism.
[16] M. Santoro,et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. , 2007, The Journal of clinical endocrinology and metabolism.
[17] Manjula K. Gupta,et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. , 2007, The Journal of clinical endocrinology and metabolism.
[18] R. Camp,et al. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] V. Vasko,et al. Specific pattern of RAS oncogene mutations in follicular thyroid tumors. , 2003, The Journal of clinical endocrinology and metabolism.
[20] J. Garber,et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. , 2003, The American journal of pathology.
[21] M. Nikiforova,et al. PAX8-PPAR&ggr; Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses , 2002, The American journal of surgical pathology.
[22] G. Fuller,et al. RET Oncogene Activation in Papillary Thyroid Carcinoma , 2001, Advances in anatomic pathology.
[23] C. Cheung,et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. , 2001, The Journal of clinical endocrinology and metabolism.
[24] Channing J Der,et al. Increasing complexity of Ras signaling , 1998, Oncogene.
[25] S. Hirohashi,et al. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. , 1991, Oncogene.